Cabaletta Bio, Inc. Files 8-K: Material Definitive Agreement

Ticker: CABA · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1759138

Sentiment: neutral

Topics: material-definitive-agreement, filing

TL;DR

Cabaletta Bio signed a big deal on June 11th. 8-K filed.

AI Summary

On June 11, 2025, Cabaletta Bio, Inc. entered into a Material Definitive Agreement. The filing also includes other events and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Philadelphia, Pennsylvania.

Why It Matters

This 8-K filing indicates a significant new agreement for Cabaletta Bio, Inc., which could impact its business operations and future financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood by the market.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the Material Definitive Agreement entered into by Cabaletta Bio, Inc. on June 11, 2025?

The filing does not specify the details of the Material Definitive Agreement, only that one was entered into on June 11, 2025.

What are the principal executive offices of Cabaletta Bio, Inc.?

The principal executive offices of Cabaletta Bio, Inc. are located at 2929 Arch Street Suite 600, Philadelphia, Pennsylvania, 19104.

In which state is Cabaletta Bio, Inc. incorporated?

Cabaletta Bio, Inc. is incorporated in Delaware.

What is the SEC file number for Cabaletta Bio, Inc.?

The SEC file number for Cabaletta Bio, Inc. is 001-39103.

What is the SIC code for Cabaletta Bio, Inc.?

The Standard Industrial Classification (SIC) code for Cabaletta Bio, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Cabaletta Bio, Inc. (CABA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing